Diabetic peripheral neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All selected patients meet the diagnostic criteria for DPN in the "Chinese Guidelines for the Prevention and Treatment of Type 2 Diabetes (2017 Edition)"; 2. All are patients with type 2 diabetes; 3. Duration of illness >= 5 years; 4. Michigan Neuropathy Screening Instrument (MNSI) score >= 2 points; 5. Patients and/or their family members sign the relevant informed consent form.
Exclusion criteria
Exclusion criteria: 1. Individuals with severe functional impairment of important organs such as the heart, liver, and kidneys; 2. Individuals with contraindications to the study medication; 3. Individuals with a history of cardiovascular and cerebrovascular diseases; 4. Individuals with acute or chronic infections and autoimmune diseases; 5. Individuals with mental illnesses or cognitive impairments that prevent normal communication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Motor nerve conduction velocity;Fasting blood glucose;Hypersensitive C-reactive protein;Tumor necrosis factor a; | — |
Secondary
| Measure | Time frame |
|---|---|
| Diabetes Quality of Life Specific Scale; | — |
Countries
China
Contacts
Yancheng Third People's Hospital